• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Donna Young

Articles by Donna Young

Washington roundup: Bill reauthorizing two grant programs advances in Senate

June 26, 2009
By Donna Young

Insmed Shares Tumble on Failed Phase II Iplex Trial

June 26, 2009
By Donna Young
Insmed Inc.'s stock lost more than half of its value Thursday after the Richmond, Va.-based firm said Iplex (mecasermin rinfabate), a complex of recombinant human insulin-like growth factor 1 (IGF-1) and its binding protein IGFBP-3, failed to improve endurance, muscle function or strength or quality of life in patients with myotonic muscular dystrophy (MMD), a potentially life-threatening genetic disorder. (BioWorld Today)
Read More

Protein Sciences Wins $35M HHS Pact; Fends Off Creditors

June 25, 2009
By Donna Young
WASHINGTON - Privately held Protein Sciences Corp. Inc. won a $35 million Health and Human Services (HHS) contract, which could be extended to $147 million over five years, to support the Meriden, Conn.-based firm's recombinant baculovirus influenza vaccine technology. (BioWorld Today)
Read More

Halozyme Raises $40M in Offering; Shares Fall

June 24, 2009
By Donna Young
Halozyme Therapeutics Inc., which is focused on developing and commercializing hyaluronidases targeting the extracellular matrix for endocrinology, oncology and dermatology, raised $40 million by selling 6.15 million shares of its common stock for $6.50 per share. (BioWorld Today)
Read More

Baucus, White House Strike $80B Deal on Part D Drugs

June 23, 2009
By Donna Young

Bill Permitting Much-Needed SBIR, STTR Grants in Senate

June 22, 2009
By Donna Young
WASHINGTON - Legislation introduced earlier this month by Sens. Mary Landrieu (D-La) and Olympia Snowe (R-Maine) to reauthorize the Small Business Innovation Research and the Small Business Technology Transfer programs was quickly passed last week by the Senate Committee on Small Business and Entrepreneurship. (BioWorld Today)
Read More

Eshoo Demands Compromise on Biotech-Friendly FOBs

June 19, 2009
By Donna Young

Hatch: Patent Law 'Insufficient' to Protect Biotech Products

June 18, 2009
By Donna Young

FDA Advisers Back Savient Gout Drug

June 17, 2009
By Donna Young

Washington roundup: CDC issues first guidelines governing genetic testing

June 16, 2009
By Donna Young
Previous 1 2 … 39 40 41 42 43 44 45 46 47 … 107 108 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 29, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • KT-621: a first-in-class STAT6 degrader for Th2-driven diseases

    BioWorld Science
    STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe